Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Thulin

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1976
High blood pressure related to carcinogen-induced unscheduled DNA synthesis, DNA carcinogen binding, and chromosomal aberrations in human lymphocytesR W Pero, C Bryngelsson, F Mitelman, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertensionO R Nilsson, B E Karlberg, N C Henningsen, et al.
Acta Medica Scandinavica|January 1, 1985
Both high and low blood pressures risk indicators of death in middle-aged males. Isotonic regression of blood pressure on age applied to data from a 13-year prospective studyL Lindholm, J Lanke, B Bengtsson, et al.
Journal of Internal Medicine|September 1, 1991
Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind, cross-over studyB Fagher, P Katzman, U L Hulthén, et al.
Acta Medica Scandinavica|January 1, 1979
Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activityO R Nilsson, B E Karlberg, O Ohlsson, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Deoxyribonucleic acid repair synthesis: a new factor for defining high blood pressureT Thulin, R W Pero, C Bryngelsson, et al.
Journal of Cardiovascular Pharmacology|March 1, 1990
Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertensionP L Katzman, N C Henningsen, B Fagher, et al.
Mutation Research|June 1, 1978
Interindividual variation in the responses of cultured human lymphocytes to exposure from DNA damaging chemical agents: interindividual variation to carcinogen exposureR W Pero, C Bryngelsson, F Mitelman, et al.
Journal of Hypertension|January 1, 1993
Cerebral blood flow in patients with severe hypertension, and acute and chronic effects of felodipineT Thulin, B Fagher, M Grabowski, et al.
Chirality|March 29, 2001
Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patientsH Ericsson, J Schwieler, B O Lindmark, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1976
High blood pressure related to carcinogen-induced unscheduled DNA synthesis, DNA carcinogen binding, and chromosomal aberrations in human lymphocytesR W Pero, C Bryngelsson, F Mitelman, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertensionO R Nilsson, B E Karlberg, N C Henningsen, et al.
Acta Medica Scandinavica|January 1, 1985
Both high and low blood pressures risk indicators of death in middle-aged males. Isotonic regression of blood pressure on age applied to data from a 13-year prospective studyL Lindholm, J Lanke, B Bengtsson, et al.
Journal of Internal Medicine|September 1, 1991
Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind, cross-over studyB Fagher, P Katzman, U L Hulthén, et al.
Acta Medica Scandinavica|January 1, 1979
Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activityO R Nilsson, B E Karlberg, O Ohlsson, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Deoxyribonucleic acid repair synthesis: a new factor for defining high blood pressureT Thulin, R W Pero, C Bryngelsson, et al.
Journal of Cardiovascular Pharmacology|March 1, 1990
Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertensionP L Katzman, N C Henningsen, B Fagher, et al.
Mutation Research|June 1, 1978
Interindividual variation in the responses of cultured human lymphocytes to exposure from DNA damaging chemical agents: interindividual variation to carcinogen exposureR W Pero, C Bryngelsson, F Mitelman, et al.
Journal of Hypertension|January 1, 1993
Cerebral blood flow in patients with severe hypertension, and acute and chronic effects of felodipineT Thulin, B Fagher, M Grabowski, et al.
Chirality|March 29, 2001
Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patientsH Ericsson, J Schwieler, B O Lindmark, et al.
Pageof 6